About Ocugen (OCGN)
Ocugen, Inc. is a biopharmaceutical company focused on developing gene therapies to cure blindness diseases and developing vaccine for COVID-19. The Company's technology pipeline includes: COVID-19 Vaccine (0.5), Modifier Gene Therapy Platform and N... Read more
- USD1.35
- USD1.36
- USD1.21
- USD2.11
- -24.40%
- 6M
- 85.13k
- 9.32M
- 340M
- 0.35
- 57.70%
Stock News
4 hours ago
Forget SoundHound AI: 3 Tech Stocks to Buy Instead
Yahoo
4 hours ago
This Is Hands Down My Pick for the Best "Magnificent Seven" Stock Right Now. (Hint: It's Not Nvidia.)
Yahoo
5 hours ago
Swipe Right on Safety: New Study from Norton Finds 64% of Online Daters are Interested in Using AI as a Dating Coach
Yahoo
5 hours ago
JD Sports Fashion Buys Hibbett, Valuing It at $1.1 Bln, in Push Into U.S. Market
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
